Tech Company Financing Transactions

Full-Life Technologies Funding Round

Junson Capital, Chengwei Ventures and HongShan invested in a $77 million Series C funding round for Full-Life Technologies. The round was announced on 9/30/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare IT

Mailing Address

Room A1306, 13th Floor, Building 3 No. 702, Zhongke Road
Shanghai, 201210
CN

Phone

Undisclosed

Website

www.full-life.com

Email Address

Undisclosed

Overview

Full-Life Technologies Limited ("Full-Life") is a fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Lanny Sun

        

Chief Medical Officer

Steffen Heeger

        

Chief Scientific Officer

Fa Liu

        

Browse more venture capital transactions:

Prev: 9/30/2025: Deckard Technologies venture capital transaction
Next: 9/30/2025: Supernova venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary